Atlas Trials

Nilotinib in the Treatment of Systemic Sclerosis

Clinical trial NCT01166139 · COMPLETED

Trial details

NCT number
NCT01166139
Sponsor
Hospital for Special Surgery, New York
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Systemic Sclerosis
Start date
2010-07-01
Primary completion
2014-07-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.